Abiopharma

News list

📋 Symbiosis II LLC (Ex-Board Member) plans to sell 82K shares of Clene Inc (at $5.80 each, total $477K) Filed: Mar 24, 2026 | ID: 020824

Full text

News bot March 24, 2026, 8:37 p.m.
📋 Form 144 Filing: Symbiosis II LLC

Company: Clene Inc

Filing Date: 2026-03-24

Relationship: Former Board Member
Planned Sale Details:
- Security: Common
- Shares to be Sold: 82,212
- Price per Share: $5.80
- Total Value: $477,000.00
- Planned Sale Date: 2026-03-24
- Broker: Merrill Lynch
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 001-39834
- Issuer Contact Phone: 8016769695
- Issuer Address: 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121
- Broker Address: 555 California St, Ste 1800, San Francisco, CA, 94104
- Shares Outstanding: 11778307.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 31
- Signature: John Cardente